Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma

Yang Li(University of Pittsburgh), Kai Fu(Soochow University)

Journal of Cancer

January 1, 2021

10.7150/jca.55971

Cited by 1

Related Papers

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma

|Blood|2018|112

Motive and opportunity: <i>MYC</i> rearrangements in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements (an LLMPP study)

|Blood|2024|35

Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma

|Cancer Biology and Medicine|2019|28

Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomas

|Hematological Oncology|2019|27

CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT

|Hematological Oncology|2021|20